CTOs on the Move

MAI Medical Aesthetics - Non Surgical Treatments

www.mesoexpert.com

 
MAI Medical Aesthetics - Non Surgical Treatments For Weight Loss in CA is a Roseville, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.mesoexpert.com
  • 1891 E Roseville Pkwy Ste 170
    Roseville, CA USA 95661
  • Phone: 916.786.6376

Executives

Name Title Contact Details

Similar Companies

Craneville Place Of Dalton

Craneville Place Of Dalton is a Dalton, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Northwest Medical Center

Northwest Medical Center, Inc. is a Margate, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

ION Medical

ION Medical is a Mission Viejo, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Pfizer

Pfizer is a leading research-based biopharmaceutical company. We apply science and our global resources to deliver innovative therapies that extend and significantly improve lives. We make medicines and vaccines that help people when they are sick and prevent them from getting sick in the first place, as well as some of the world`s best-known consumer healthcare brands. Every day, our colleagues work in developed and emerging markets to treat, cure and eradicate life-threatening conditions and challenge some of the most feared diseases of our time. Pfizer also collaborates with healthcare providers, governments and local communities to support and expand access to reliable, affordable healthcare around the world. For more than 150 years, Pfizer has worked to make a difference for all who rely on us.

RaNA Therapeutics

RaNA Therapeutics is pioneering the discovery of a new class of RNA-targeted medicines that selectively activate protein expression within the body`s own cells. By targeting specific genes, RaNA`s novel drugs work epigenetically to precisely upregulate the expression of beneficial proteins in order to treat or prevent disease. The company`s leadership leverages preeminent founders and advisors in the field, and the strength of its fundamental patents, technology, and know-how that underlie the discovery and development of therapeutics that selectively activate RNA. RaNA is applying its proprietary technology to rapidly advance a pipeline of novel drugs for diverse therapeutic areas, with an initial emphasis in the fields of rare genetic disorders, inflammation, oncology, metabolic diseases and neurodegenerative diseases.